Prismasol B0

Prismasol B0 Overdosage

Manufacturer:

Baxter Healthcare

Distributor:

Zuellig Pharma
Full Prescribing Info
Overdosage
Overdose with Prismasol B0 substitution fluid should not occur if the procedure is carried out correctly and the fluid balance, electrolyte and acid-base balance of the patient are carefully monitored.
However, overdose could lead to severe consequences, such as congestive heart failure, electrolyte or acid-base disturbances.
If hypervolaemia or hypovolaemia occur, this should be corrected immediately. If electrolyte imbalance and acid-base balance abnormalities (e.g., metabolic alkalosis, hypophosphataemia, hypokalaemia, etc.) occur, stop administration promptly. There is no specific antidote for overdose. The risk can be minimized by close monitoring and adequate supplementation during treatment (see Precautions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in